Osteoporosis, Postmenopausal: all 337 studies

Page 1 of 4. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With OsteoporosisNot yet recruitingNCT07875894Not applicable
• Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone MassNot yet recruitingNCT07806331Phase 2
• High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized TrialNot yet recruitingNCT07734922Not applicable
• Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women?RecruitingNCT07677072
• A Retrospective and Prospective Clinical Registry for Data Collection of Perimenopausal, Menopausal and Premature Ovarian Insufficiency WomenNot yet recruitingNCT07606326
• The Comparison of Ibandronate and Zoledronic Acid After Denosumab DiscontinuationRecruitingNCT07406685Phase 4
• Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal FemalesRecruitingNCT07365514Phase 1
• AGE Burden and Response to Antiresorptive Therapy in OsteoporosisNot yet recruitingNCT07329543
• COMPASS - COpenhagen MenoPAuSe StudyRecruitingNCT07254429Phase 2
• Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex RelationshipRecruitingNCT07253493Not applicable
• The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis PatientsRecruitingNCT07231822Not applicable
• Prunes Preventing Bone Loss in PerimenopauseRecruitingNCT07120997Not applicable
• Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.Enrolling by invitationNCT07120854Not applicable
• Evaluation of Osteo-Buddy in Improving Osteoporosis KnowledgeNot yet recruitingNCT07034131Not applicable
• Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal OsteoporosisNot yet recruitingNCT06951776Not applicable
• Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis PatientsRecruitingNCT06938152Phase 4
• Efficacy of OsteoBor in Postmenopausal OsteoporosisNot yet recruitingNCT06809816Phase 2
• StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosisRecruitingNCT06767150Phase 4
• Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility FracturesNot yet recruitingNCT06720350Phase 4
• Stress Urinary Incontinence and Sarcopenia in Postmenopausal OsteoporosisRecruitingNCT06655701
• Combined Anabolic TherapyRecruitingNCT06558188Phase 4
• New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics TechnologiesRecruitingNCT06525688
• Virtual perI-/Menopause Registry of AusTrALiaRecruitingNCT06487130
• Sequential Therapies After Osteoanabolic TreatmentRecruitingNCT06164795
• Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild OsteoporosisRecruitingNCT05902078Phase 4
• Mechanisms of Anabolic Osteoporosis TherapyRecruitingNCT05688969Not applicable
• Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal OsteoporosisRecruitingNCT05571514Not applicable
• Denosumab Biosimilar Injection in Post Menopausal Women With OsteoporosisRecruitingNCT05419427Phase 3
• Vascular Function, Sarcopenia and Pain in Postmenopausal OsteoporosisRecruitingNCT05228262Not applicable
• A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.CompletedNCT06079476Phase 4Results posted
• A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®CompletedNCT05405725Phase 3Results posted
• Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBONDCompletedNCT05395091Phase 3Results posted
• A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.CompletedNCT05338086Phase 3Results posted
• Lactobacillus Acidophilus and Postmenopausal WomenCompletedNCT05332626Not applicableResults posted
• Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal OsteoporosisCompletedNCT05087030Phase 3Results posted
• Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal WomenCompletedNCT04974723Results posted
• Effect of GLP-1 Receptor Agonists on Trabecular Bone ScoreTerminatedNCT04964388Phase 2Results posted
• A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With OsteoporosisCompletedNCT04934072Phase 3Results posted
• A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisCompletedNCT04729621Phase 3Results posted
• A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With OsteoporosisCompletedNCT04664959Phase 3Results posted
• Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD RiskCompletedNCT04431960Phase 1Results posted
• Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)CompletedNCT04366726Phase 1Results posted
• Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD)TerminatedNCT04271605Not applicableResults posted
• Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal OsteoporosisCompletedNCT04149405Phase 4Results posted
• Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With OsteoporosisCompletedNCT04064411Phase 3Results posted
• Bone Modeling Effects of Combined Anabolic/Antiresorptive AdministrationCompletedNCT04026256Phase 4Results posted
• Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal OsteoporosisCompletedNCT03974100Phase 3Results posted
• Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and ResorptionCompletedNCT03710889Phase 3Results posted
• A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for OsteoporosisCompletedNCT03432533Phase 3Results posted
• Effect of VSL#3 on Bone Mineral Density in Postmenopausal WomenTerminatedNCT03165747Phase 2Results posted
• A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With OsteoporosisCompletedNCT02791516Phase 3Results posted
• Preventing Osteoporosis Using DenosumabCompletedNCT02753283Phase 4Results posted
• A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal OsteoporosisCompletedNCT02598934Phase 4Results posted
• Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)CompletedNCT02589600Phase 4Results posted
• A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal WomenTerminatedNCT02337387Phase 1Results posted
• A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal WomenCompletedNCT02247011Not applicableResults posted
• Denosumab and Teriparatide Study (DATA-HD and DATA-EX)CompletedNCT02176382Phase 4Results posted
• A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With OsteoporosisCompletedNCT02157948Phase 3Results posted
• A Study of Blosozumab (LY2541546) in Postmenopausal Female ParticipantsCompletedNCT02109042Phase 1Results posted
• A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With OsteoporosisCompletedNCT02016716Phase 3Results posted
• Denosumab China Phase III StudyCompletedNCT02014467Phase 3Results posted
• Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal OsteoporosisCompletedNCT01992159Phase 2Results posted
• An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCompletedNCT01796301Phase 3Results posted
• Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone ResorptionCompletedNCT01750086Phase 4Results posted
• Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With OsteoporosisCompletedNCT01732770Phase 4Results posted
• VERtebral Fracture Treatment Comparisons in Osteoporotic WomenCompletedNCT01709110Phase 4Results posted
• Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With OsteoporosisCompletedNCT01674621Phase 2Results posted
• Observational Study of Denosumab (Prolia®) in Postmenopausal Women With OsteoporosisCompletedNCT01668589Results posted
• Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With OsteoporosisCompletedNCT01657162Phase 3Results posted
• Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical PracticeCompletedNCT01652690Results posted
• Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With OsteoporosisCompletedNCT01575834Phase 3Results posted
• A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of DenosumabCompletedNCT01495000Phase 3Results posted
• A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of DenosumabCompletedNCT01457950Phase 3Results posted
• Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)CompletedNCT01416194Results posted
• A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)CompletedNCT01350934Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal WomenCompletedNCT01343004Phase 3Results posted
• Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal WomenCompletedNCT01321723Phase 2Results posted
• A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal OsteoporosisCompletedNCT01292187Phase 2Results posted
• A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal OsteoporosisCompletedNCT01290094Phase 3Results posted
• A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal WomenCompletedNCT01250145Phase 1Results posted
• The Effects of Denosumab on the Pharmacokinetics (PK) of MidazolamCompletedNCT01221727Phase 1Results posted
• MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)CompletedNCT00996801Phase 2Results posted
• A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic WomenCompletedNCT00959764Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly BisphosphonatesCompletedNCT00936897Phase 3Results posted
• Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic WomenCompletedNCT00927186Phase 4Results posted
• Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal WomenCompletedNCT00918749Phase 2Results posted
• Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00896532Phase 2Results posted
• A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With DenosumabCompletedNCT00890981Phase 3Results posted
• A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With DenosumabCompletedNCT00887965Phase 2Results posted
• Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With OsteoporosisCompletedNCT00745121Not applicableResults posted
• Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)CompletedNCT00729651Phase 4Results posted
• 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 YrsCompletedNCT00718861Phase 3Results posted
• Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)CompletedNCT00620113Phase 2Results posted
• A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With TeriparatideCompletedNCT00557310Phase 4Results posted
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva TreatmentCompletedNCT00551174Phase 4Results posted
• BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.CompletedNCT00545779Phase 3Results posted
• A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)CompletedNCT00545363Phase 4Results posted
• A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.CompletedNCT00545051Phase 4Results posted
• A Study of a 35 mg Delayed Release Formulation of Risedronate for OsteoporosisCompletedNCT00541658Phase 3Results posted
• A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)TerminatedNCT00529373Phase 3Results posted

← Osteoporosis, Postmenopausal overview